It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Recent advancements in plasma lipidomic profiling methodology have significantly increased specificity and accuracy of lipid measurements. This evolution, driven by improved chromatographic and mass spectrometric resolution of newer platforms, has made it challenging to align datasets created at different times, or on different platforms. Here we present a framework for harmonising such plasma lipidomic datasets with different levels of granularity in their lipid measurements. Our method utilises elastic-net prediction models, constructed from high-resolution lipidomics reference datasets, to predict unmeasured lipid species in lower-resolution studies. The approach involves (1) constructing composite lipid measures in the reference dataset that map to less resolved lipids in the target dataset, (2) addressing discrepancies between aligned lipid species, (3) generating prediction models, (4) assessing their transferability into the targe dataset, and (5) evaluating their prediction accuracy. To demonstrate our approach, we used the AusDiab population-based cohort (747 lipid species) as the reference to impute unmeasured lipid species into the LIPID study (342 lipid species). Furthermore, we compared measured and imputed lipids in terms of parameter estimation and predictive performance, and validated imputations in an independent study. Our method for harmonising plasma lipidomic datasets will facilitate model validation and data integration efforts.
Advancements in plasma lipidomic profiling increase specificity of measurements but pose challenges in aligning datasets created at different times or platforms. Here the authors present a predictive framework for harmonising such datasets with different levels of granularity in their lipid measurements.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details












1 Baker Heart and Diabetes Institute, Melbourne, Australia (GRID:grid.1051.5) (ISNI:0000 0000 9760 5620)
2 Baker Heart and Diabetes Institute, Melbourne, Australia (GRID:grid.1051.5) (ISNI:0000 0000 9760 5620); La Trobe University, Baker Department of Cardiovascular Research, Translation and Implementation, Melbourne, Australia (GRID:grid.1018.8) (ISNI:0000 0001 2342 0938); The University of Melbourne, Baker Department of Cardiometabolic Health, VIC, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X)
3 Baker Heart and Diabetes Institute, Melbourne, Australia (GRID:grid.1051.5) (ISNI:0000 0000 9760 5620); La Trobe University, Baker Department of Cardiovascular Research, Translation and Implementation, Melbourne, Australia (GRID:grid.1018.8) (ISNI:0000 0001 2342 0938)
4 Baker Heart and Diabetes Institute, Melbourne, Australia (GRID:grid.1051.5) (ISNI:0000 0000 9760 5620); The University of Melbourne, Baker Department of Cardiometabolic Health, VIC, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X)
5 The University of Sydney, School of Mathematics and Statistics, Camperdown, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X); The University of Sydney, Charles Perkins Centre, Camperdown, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X)
6 The University of Sydney, Kolling Institute of Medical Research, St Leonards, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X); Royal North Shore Hospital, Department of Cardiology, St Leonards, Australia (GRID:grid.412703.3) (ISNI:0000 0004 0587 9093)
7 School of Medicine at University of Texas Rio Grande Valley, Department of Human Genetics and South Texas Diabetes and Obesity Institute, Brownsville, USA (GRID:grid.449717.8) (ISNI:0000 0004 5374 269X)
8 University of Sydney, National Health and Medical Research Council of Australia (NHMRC) Clinical Trials Centre, Sydney, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X)
9 Baker Heart and Diabetes Institute, Melbourne, Australia (GRID:grid.1051.5) (ISNI:0000 0000 9760 5620); La Trobe University, Baker Department of Cardiovascular Research, Translation and Implementation, Melbourne, Australia (GRID:grid.1018.8) (ISNI:0000 0001 2342 0938); The University of Melbourne, Baker Department of Cardiometabolic Health, VIC, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X); Monash University, Department of Diabetes, Central Clinical School, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857)